Holen Sie sich die Stockscreener-App
0.8882
2.93%
-0.0268
Hoth Therapeutics Inc Aktie (HOTH) Neueste Nachrichten
Risk Analysis: Can BSVN expand into new marketsMarket Activity Report & Verified Stock Trade Ideas - baoquankhu1.vn
Market Trends: Whats the outlook for Hoth Therapeutics Incs sectorGDP Growth & Verified Short-Term Plans - baoquankhu1.vn
Pharma News: What are the risks of holding Aduro Clean Technologies IncMarket Weekly Review & AI Forecast Swing Trade Picks - baoquankhu1.vn
Bear Alert: Can National Energy Services Reunited Corp Equity Warrant keep up with sector leaders2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Hoth reports positive interim results for cancer skin therapy By Investing.com - Investing.com Nigeria
Hoth Therapeutics Early Cancer Trial Succeeds With 100% Patient Response, Cuts Disease Severity By Half - Benzinga
Hoth Therapeutics stock rises after positive interim trial results By Investing.com - Investing.com South Africa
Hoth Therapeutics stock rises after positive interim trial results - Investing.com
Hoth reports positive interim results for cancer skin therapy - Investing.com
Cancer patients on EGFR drugs report less toxicity and itch with HT-001 - Stock Titan
Hoth Therapeutics secures Chinese patent for cancer cell therapy By Investing.com - Investing.com Nigeria
Hoth Therapeutics gains after winning China patent for HT-KIT cancer program - MSN
Sell Signal: What’s the outlook for Hoth Therapeutics Inc.’s sector2025 Price Action Summary & Expert Verified Movement Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Hoth Therapeutics stock rises after securing Chinese patent for cancer therapy By Investing.com - Investing.com Australia
Hoth Therapeutics stock rises after securing Chinese patent for cancer therapy - Investing.com Nigeria
Hoth Therapeutics secures Chinese patent for cancer cell therapy - Investing.com
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position - PR Newswire
Aug Analyst Calls: Can Salarius Pharmaceuticals Inc continue delivering strong returnsJuly 2025 Patterns & High Conviction Investment Ideas - baoquankhu1.vn
Why Hoth Therapeutics Inc. stock could outperform in 2025July 2025 Review & Low Drawdown Investment Strategies - bollywoodhelpline.com
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% - MSN
Hoth Therapeutics highlights obesity and pipeline progress to regulators - TipRanks
Hoth Therapeutics, Inc. Presents New Drug Development Initiatives - TradingView — Track All Markets
Hoth Therapeutics receives positive EU regulatory decision for cancer trial By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Cancer trial to test topical drug for skin side effects from therapy - Stock Titan
Hoth Therapeutics receives positive EU regulatory decision for cancer trial - Investing.com
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing Ht-001 Oncology Trial Toward Multi-Country Site Activation - TradingView
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation - PR Newswire
Is Hoth Therapeutics Inc stock trending bullishPortfolio Performance Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Published on: 2026-01-14 02:28:37 - baoquankhu1.vn
Gap Down: What Wall Street predicts for Hoth Therapeutics Inc stock priceJuly 2025 Technicals & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Growth Value: Is Hoth Therapeutics Inc. stock supported by innovation pipelineEarnings Growth Report & Risk Managed Investment Signals - Улправда
Big Money Moves: Why Hoth Therapeutics Inc. stock could outperform in 2025Trade Analysis Summary & Fast Momentum Stock Entry Tips - ulpravda.ru
Why Hoth Therapeutics Inc. stock remains resilient2025 Momentum Check & Free Long-Term Investment Growth Plans - Улправда
Can Hoth Therapeutics Inc. stock weather global recessionWeekly Stock Report & Risk Controlled Daily Plans - Улправда
Will Hoth Therapeutics Inc. stock beat EPS estimatesJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - Улправда
Volume Summary: Why Hoth Therapeutics Inc. stock could outperform in 2025Portfolio Return Report & Safe Capital Growth Tips - ulpravda.ru
Hoth Therapeutics Files Dual U.S. Provisional Patents to Expand Oncology Dermatology IP - Digital Health News
Hoth Therapeutics Files Two Provisional Patents To Build Oncology Dermatology Platform - Nasdaq
Hoth Therapeutics Files Two US Provisional Patents for Oncology-Focused Dermatology Platform; Shares Rise - marketscreener.com
Hoth Therapeutics Files New Patents to Expand Oncology Dermatology Platform - Contract Pharma
Hoth therapeutics files patents for oncology skin toxicity treatments By Investing.com - Investing.com Canada
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments - Investing.com Nigeria
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments By Investing.com - Investing.com South Africa
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):